Variables

Incidence of TBC

COR (95% CI)

AOR (95% CI)

P-Value

Yes

No

Age

15 - 24

25 - 34

35 - 44

≥45

8 (12.1)

46 (19.6)

33 (24.1)

19 (32.8)

58 (87.9)

189 (80.4)

104 (75.9)

39 (67.2)

1

1.76 (0.78, 3.95)

2.30 (0.99, 5.31)

3.53 (1.41, 8.87

-

Disclosure status

Disclosed

Not disclosed

106 (21.5)

0 (0.0)

386 (78.5)

4 (100)

2.51 (1.27-4.98)

1

-

Family size

≤2

3 - 4

≥5

19 (15.0)

55 (24.9)

32 (21.6)

108 (85.0)

166 (75.1)

116 (78.4)

1

1.88 (1.06, 3.35)

1.57 (0.84, 2.93)

1

2.26 (1.14 - 4.50)

1.76 (0.83 - 3.69)

0.02

0.14

Cigarette smoking

Yes

No

20 (46.5)

86 (19.0)

23 (53.6)

367 (81.0)

3.71 (1.95, 7.06)

1

2.82 (1.27 - 6.27)

1

0.011

ART intervention

Pre-ART

HAART

16 (11.7)

90 (25.1)

121 (88.3)

269 (74.9)

1

2.53 (1.43, 4.49)

-

Type of initial regimen

1a

1b

1c

1d

1e + 1f

19 (11.7)

19 (29.7)

5 (8.3)

13 (23.6)

34 (24.3)

121 (88.3)

45 (70.3)

21 (52.5)

55 (91.7)

42 (76.4)

1.32 (0.68, 2.55)

2.82 (1.36, 5.85)

0.28 (0.11, 0.76)

0.96 (0.46, 2.00)

1

-

Past TB treatment history

Yes

No

22 (32.4)

84 (19.6)

46 (67.6)

344 (80.4)

1.96 (1.12, 3.43)

1

-

WHO clinical stage

I

II

III

IV

7 (6.1)

6 (3.5)

76 (43.9)

17 (44.7)

108 (93.9)

164 (96.5)

97 (56.1)

21 (55.3)

1

0.56 (0.18, 1.72)

12.0 (5.31, 27.5)

12.5 (4.61, 33.8)

1

0.33 (0.06 - 1.86)

20.26 (7.09 - 57.6)

22.9 (6.91 - 76.4)

0.21

<0.001

<0.001

CD4 count

<50

50 - 100

101 - 200

200

20 (57.1)

23 (39.7)

38 (29.9)

25 (9.1)

15 (42.5)

35 (60.3)

89 (70.1)

251 (90.9)

13.4 (6.10, 29.4)

6.59 (3.38, 12.8)

4.28 (2.44, 7.50)

1

Hemoglobin

<10

≥10

24 (48) 82 (18.4)

26 (52) 364 (81.6)

1

3.46 (1.30, 9.18)

1

2.56 (1.22 - 5.33)

0.012